Stockscreener 앱 받기
7.36
4.69%
0.33
시장 영업 전:
7.52
0.16
+2.17%
Tempest Therapeutics Inc 주식(TPST)의 최신 뉴스
Real time alert setup for Tempest Therapeutics Inc. performanceInvestment Life Cycle Planning Summary - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionFree Step-by-Step Trade Signal Implementation - Newser
Tempest Therapeutics Inc. stock chart pattern explainedSummary of Trade Cycles in 5-Year Range - Newser
What makes Tempest Therapeutics Inc. stock price move sharplySafe Momentum Strategy With Trend Analysis - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoverySmart Stock Forecast Using AI Algorithms - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent moveSupport and Resistance Zone Summary Chart - Newser
Is it too late to sell Tempest Therapeutics Inc.Safe Momentum Strategy With Trend Analysis - Newser
Published on: 2025-08-10 01:25:41 - Newser
What technical models suggest about Tempest Therapeutics Inc.’s comeback - Newser
Multi factor analysis applied to Tempest Therapeutics Inc.Short Term Gain Strategy with AI Logic - Newser
Tempest Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayROI Focused Setup Screener With Exit Markers - Newser
Published on: 2025-08-09 23:28:19 - Newser
What data driven models say about Tempest Therapeutics Inc.’s futureBuy Signal Forecast With Short-Term Data - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Chart Breakout Buy Signal Detection - Newser
Tempest Therapeutics Inc. stock outlook for YEARReliable Setup Screener with Low Risk - Newser
Tempest Therapeutics Inc expected to post a loss of $2.60 a shareEarnings Preview - TradingView
Is Tempest Therapeutics Inc. stock bottoming outWeekly Hot Stocks Based on Volume Flow - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.Buy Candidate Summary Based on Fundamentals - Newser
Tempest Therapeutics (TPST) Expected to Announce Quarterly Earnings on Thursday - Defense World
Long term hold vs stop loss in Tempest Therapeutics Inc.Smart Forecast Signals from AI Models - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockFree Buy Low Sell High Stock Watch - Newser
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceAI Trading Forecast Based on Big Data - Newser
Morpheus-Liver Study: A New Horizon in Advanced Liver Cancer Treatment - TipRanks
What analysts say about Tempest Therapeutics Inc. stockCapitalize on market trends before they peak - Jammu Links News
Is it the right time to buy Tempest Therapeutics Inc. stockUnlock high-yield investment opportunities - Jammu Links News
Is Tempest Therapeutics Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):